2329 |
FFR State-of-the-Art: Clinical Applications and New Technologies |
William F. Fearon |
Apr. 20. 15 |
2328 |
Drug-Coated Balloons: Technology, Clinical Outcomes, and Future Promise |
Phillippe Genereux |
Apr. 20. 15 |
2327 |
Ultimate Comparison: Sapien vs. Corevalve |
Eberhard Grube |
Apr. 20. 15 |
2326 |
Bioresorbable Scaffolds in a "Nutshell": Updates and Expectations |
Gregg W. Stone |
Apr. 20. 15 |
2325 |
New Metallic DES: Bioresorbable Polymers or Polymer-Free |
Patrick W. Serruys |
Apr. 20. 15 |
2324 |
Expanding the Indications of Transcatheter Aortic Valve Replacement |
Alain G. Cribier |
Apr. 20. 15 |
2323 |
Randomzed Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: Five-Year Outcomes of the PRECOMBAT Study |
Jung-Min Ahn |
Apr. 20. 15 |
2322 |
Evolving Transcatheter Mitral Valve Repair and Replacement Therapies |
Ted Feldman |
Apr. 20. 15 |
2321 |
Which TAVI Devices to Use: A Multi-Device Patient-Specific Approach |
Eberhard Grube |
Apr. 20. 15 |
2320 |
"Minimalist" TAVI: User-Friendly and with Optimal Clinical Outcomes |
Alain G. Cribier |
Apr. 20. 15 |